Industry News
Medical Device Industry News
Wolters Kluwer Health Launches ClinicalPulse™ | A Simplified Continuing Education Solution for Nurse Practitioners
Rafael Sidi, Senior Vice President & General Manager of Health Research, Wolters Kluwer Health. “In the current healthcare landscape, NPs are facing demanding workloads paired with staying current on the latest medical evidence to ensure
Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution
“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking
Avenacy Announces Launch of Palonosetron Hydrochloride Injection, USP in the U.S. Market
Avenacy's Palonosetron Hydrochloride Injection, USP is available in 0.25 mg/5 mL (0.05 mg per mL) single-dose vials. In line with Avenacy’s mission to champion patient safety and streamline patient care, Palonosetron Hydrochloride Injection, USP will
Agilent Technologies to Acquire North American CDMO BIOVECTRA
BIOVECTRA and Agilent Technologies are fully integrated CDMOs with state-of-the-art facilities that follow current Good Manufacturing Practices (cGMP), a high standard for methods, facilities, and controls used in manufacturing, processing, and packaging of active pharmaceutical
Spryte Medical Receives Breakthrough Device Designation from FDA for Revolutionary neuro Optical Coherence Tomography (nOCT) Technology
“Our engagement with the FDA through the Breakthrough Device and Total Product Life Cycle Advisory Program (TAP), highlights the potential of Spryte Medical’s neuro OCT imaging platform for patients with cerebrovascular disease” said David Kolstad,
TCBP Announces Dosing of 6th Patient in ACHIEVE Study in Patients with Acute Myeloid Leukemia
The ACHIEVE Study UK clinical trial is an open-label, phase II study designed to evaluate the efficacy and effectiveness of TCB-008 in patients with AML or MDS/AML, with either refractory or relapsed disease. ACHIEVE is
Grünenthal Acquires US-company Valinor Pharma and Becomes Global Owner of Movantik®
"As a pain specialist, Movantik is a perfect fit for Grünenthal with our existing customer base and complementary product portfolio", says Gabriel Baertschi, CEO, Grünenthal. "The acquisition of Valinor Pharma strengthens our footprint in the United States,
RedHill Biopharma Strengthens Cash Balance, Settles Obligations and Removes Talicia® Lien
Razi Ingber, RedHill Biopharma and Chief Financial Officer, said: "We are very pleased to reach this smooth conclusion, which strengthens RedHill's cash position and greatly enhances our ability to manage our cash. The Agreement eliminates
Nima Farzan: New CEO at Latigo Biotherapeutics
Nima Farzan brings more than two decades' leadership experience with a strong track record in fundraising and IPOs.
eCential Robotics Receives FDA 510(k) Clearance for Spine Navigation and Robotic-Assistance Device
"This additional FDA clearance is a testament to our relentless pursuit of innovation and excellence in the field of surgical robotics and navigation," said Clément Vidal, CEO at eCential Robotics. "We look forward to continuing
Dasyo Welcomes Medical Aesthetics Industry Icon Domenic Serafino (Dom) as Executive Chair
Domenic Serafino was part of the start-up executive team at Syneron Medical Corp acting as its President of North America and Executive Vice President - Syneron Medical Israel. He was instrumental in helping Syneron IPO in
When to Call a Plumber: Signs You Need Professional Help
Are you dealing with plumbing problems that you can’t solve? You’re not alone. Plumbing issues range from slight inconveniences to life-altering disasters, and knowing the difference between the two can save you money and time.
Oblemic: A Comprehensive Review & Latest Research
Oblemic Reviews suggest that by integrating this supplement with healthy lifestyle choices, individuals may see significant improvements in their health. Unlike injectable treatments such as Ozempic and Wegovy, Oblemic is designed to provide similar benefits
How Technology Is Driving Person-Enabled Brain Health, Fueling Better Outcomes and Options | By Mark Lehmkuhle, PhD, CEO, Founder of Epitel
In brain health, traditional inpatient monitoring systems present a myriad of barriers. They often require travel to a specialized health center, are cumbersome and restrictive for patients, and technical requirements and limitations impede providers' ability
Ora Announces Strategic Investment from The Vistria Group to Propel Global Growth, Enhance Customer Experience in Ophthalmic Research
With this investment, The Vistria Group will support Ora as the globally preferred clinical research partner of ophthalmic innovators. It also marks The Vistria Group’s commitment to further supporting cutting-edge therapies and advancing diversity in
Dana-Farber Cancer Institute Nurses Have Voted to Ratify New MNA Contract | Featuring Significant Investment in Nursing and Patient Care
Registered nurses and nurse practitioners voted overwhelmingly to finalize an agreement reached in June to help DFCI recruit and retain the nurses needed to provide world-class cancer care .
New Paper Underscores Inflammation’s Role in Atherosclerosis
Peter Libby, MD, President, of the International Atherosclerosis Society and Chair of the White Paper Expert Panel said, "Atherosclerosis is a primary cause of cardiovascular disease, the leading cause of death worldwide. This paper underscores
Bloom Nutrition Introduces Bloom Sparkling Energy Drinks
"Our mission is to help everyone bloom into their best selves, and energy consistently comes up as a key concern for Bloom consumers," says Mari Llewellyn, co-founder of Bloom Nutrition. "We heard our community's demands
Meitheal Pharmaceuticals Expands Specialty Biopharmaceuticals Portfolio with Acquisition of CONTEPO™ (Fosfomycin for Injection) from Nabriva Therapeutics
Under the Asset Purchase Agreement, Meitheal Pharmaceuticals acquires North America rights to CONTEPO™, including any results of development and regulatory activities, and all intellectual property (IP) rights, technology, and know-how related to CONTEPO™. In exchange,
Hanger Ventures Announces Inaugural Investment
“We are thrilled to make our inaugural investment in Bionic Power,” shared James Campbell, Ph.D., Hanger Ventures President and Hanger, Inc. Chief Clinical Officer. “We look forward to contributing clinical research, along with technical and